2026

1. Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU

   Therapeutic Advances in Gastroenterology, Vol. 19

2. CEBPA-bZIP Mutations in AML Patients Treated With Non-Intensive Therapy: A Study by the Spanish PETHEMA Registry

   Hematological Oncology, Vol. 44, Núm. 1

3. Clinical Factors Associated With Current Relevance in Allergic Contact Dermatitis: Development of Predictive Models Based on Data From the Spanish Contact Dermatitis Register (REIDAC)

   Contact Dermatitis, Vol. 94, Núm. 6, pp. 614-623

4. Comparable Inflammatory and Metabolic Outcomes after Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults with HIV (INSTINCT/GESIDA10918 Study)

   Clinical Infectious Diseases, Vol. 82, Núm. 2, pp. e262-e274

5. Corrigendum to ‘Pre-emptive TIPS should be considered in high-risk patients with both acute variceal bleeding and severe alcohol-related hepatitis’ (JHEP Reports 7 [2025] 101611) (JHEP Reports (2025) 7(12), (S2589555925002939), (10.1016/j.jhepr.2025.101611))

   JHEP Reports

6. Defining ascending aorta dilatation in pediatric bicuspid aortic valve: Comparison of known classical and new z-score nomograms, and anthropometric parameters indexing for its assessment

   Journal of Cardiology, Vol. 87, Núm. 4, pp. 375-382

7. Designing interventions guided by digital phenotype and pharmacogenetics in Spain for suicidal behaviour based on retrospective data: the multicentre SMARTomicS study protocol

   BMJ Open , Vol. 16, Núm. 5

8. Early portopulmonary hypertension predicts mortality in patients with cirrhosis: Insights from the PORTO-DETECT cohort

   Journal of Hepatology, Vol. 84, Núm. 2, pp. 284-292

9. Effectiveness of a Comprehensive Program Including a Novel Concentrated High-Protein, High-Calorie Oral Nutritional Supplement to Enhance Nutritional and Morphofunctional Recovery in Malnourished Patients with Cancer: The ONAVIDA Study

   Nutrients , Vol. 18, Núm. 9

10. Efficacy and safety of sepiapterin versus sapropterin in patients with phenylketonuria: Results from the Phase 3, randomized, crossover, open-label, active-controlled AMPLIPHY trial

    Metabolism: Clinical and Experimental, Vol. 178

11. Epidemiological, Clinical and Allergic Profile of Patients With Dyshidrotic Eczema (Acute and Recurrent Vesicular Dermatitis): Evaluation of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy (REIDAC)

    Contact Dermatitis

12. Evolving Patterns of EBV-Associated PTLD After Allogeneic Stem Cell Transplantation: Frequency, Characteristics and Outcomes in a Multicenter GETH-TC Study

    European Journal of Haematology, Vol. 116, Núm. 4, pp. 450-457

13. Executive summary of the consensus document on management of the transition of patients with Inborn errors of intermediary metabolism

    Revista Clinica Espanola

14. Growth Hormone Assay-Adjusted Standardization Reveals Distinct Clinical Phenotypes in Acromegaly

    Endocrine Practice, Vol. 32, Núm. 2, pp. 236-245

15. Impact of Sleep-disordered Breathing Management in Primary Care on Systemic Hypertension Control: Protocol for the METASLEEP Implementation Trial

    Open Respiratory Archives, Vol. 8, Núm. 1

16. Influence of the level of education on cognitive function in Parkinson’s disease

    Journal of Neural Transmission, Vol. 133, Núm. 4, pp. 663-681

17. Interlaboratory cross validation of acute myeloid leukemia fusion genes and mutational targets detected by PCR: Performance of PETHEMA central laboratories

    Leukemia Research, Vol. 160

18. Oxygen saturation and mortality for acute pulmonary embolism: multinational retrospective cohort study

    eClinicalMedicine, Vol. 94

19. Peak Inspiratory Flow Capability for Simulated Dry Powder Inhaler Resistances in Asthma Patients Prescribed Pressurized Metered-Dose Inhalers with Valved Holding Chambers: The USE-DPI Study

    Journal of Clinical Medicine, Vol. 15, Núm. 8

20. Perioperative and periprocedural management of antithrombotic therapy: 2025 consensus document of SEC, SEDAR, SEACV, SECCE, AEC, SECOM CYC, SECPRE, SEPD, SEGG, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEN, S.E.N., SENEC, SEPAR, SEO, SEORL-CCC, SEPA, SERVEI, SECOT, and AEU

    Revista Espanola de Cardiologia, Vol. 79, Núm. 1, pp. 68-79